CompletedNot applicableNCT05074251
Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV
Studying Lethal ataxia with deafness and optic atrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, Los Angeles
- Principal Investigator
- Kristin Wall, PhDEmory University
- Intervention
- HIV self test(diagnostic_test)
- Enrollment
- 180 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2021 – 2021
Study locations (1)
- Department of Health Clinics, Nkangala, Mpumalanga, South Africa
Collaborators
Emory University · BroadReach Healthcare · United States Agency for International Development (USAID) · Mpumalanga Department of Health
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05074251 on ClinicalTrials.govOther trials for Lethal ataxia with deafness and optic atrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT06374758Accelerated ART Initiation for PWHIV Who Are Out of CareUniversity of Missouri-Columbia
- RECRUITINGNANCT05912270Orchestra in Class, a Novel Booster for Executive Functions and Brain Development in Young Primary School ChildrenSchool of Health Sciences Geneva
- ACTIVE NOT RECRUITINGNANCT06176859Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) StudyMassachusetts General Hospital
See all trials for Lethal ataxia with deafness and optic atrophy →